Search - tctmd.com

Displaying 1 - 20 of 89

Sort: Relevancy | Date

News Daily News

JACC Debuts Data Digest on CV Health in the United States

Caitlin E. Cox

January 12, 2026

News Daily News

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

Michael O'Riordan

January 08, 2026

News Daily News

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

Michael O'Riordan

December 18, 2025

News Conference News AHA 2025

Metformin Before Catheter Ablation for AF Helps Nondiabetic Patients With Overweight

Caitlin E. Cox

November 18, 2025

News Daily News

Oral Semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients

Caitlin E. Cox

October 22, 2025

News Daily News

Weight-Loss Drug MariTide Gains Momentum in Phase II Trial

Caitlin E. Cox

June 25, 2025

News Daily News

Eye Condition a ‘Very Rare’ Side Effect of Semaglutide, EMA Says

Todd Neale

June 06, 2025

News Opinion CV Team Dispatch

April 2025 Dispatch for the CV Team

L.A. McKeown

April 18, 2025

News Opinion CV Team Dispatch

January 2025 Dispatch for the CV Team

L.A. McKeown

January 24, 2025

News Daily News

Top General Cardiology and Prevention News of 2024

Caitlin E. Cox

December 30, 2024

News Daily News

Rural Counties Bore Brunt of Worsening CV Mortality During Pandemic

Yael L. Maxwell

November 15, 2024

News Daily News

The Cardiovascular Consequences of War

Todd Neale

October 23, 2024

News Features

Can ‘Body Roundness Index’ Replace BMI? That Depends, Say Experts

Michael O'Riordan

October 21, 2024

News Daily News

Medicaid Coverage Improves CV Risk in Some, Post Hoc Analysis Shows

Todd Neale

September 25, 2024

News Conference News ESC 2024

More Data Diminish Support for Cath Lab Fasting Rules: SCOFF

L.A. McKeown

September 10, 2024

News Conference News ESC 2024

FINEARTS-HF: Benefit of Finerenone Extends to HFmrEF and HFpEF Patients

Michael O'Riordan

September 01, 2024

News Daily News

‘Disproportionate’ Suicide/Self-Harm Signal With Semaglutide: WHO Database

Michael O'Riordan

August 21, 2024

News Daily News

‘Smoldering Epidemic’ of CVD Risk Factors in Middle-Aged Adults

Michael O'Riordan

November 21, 2023

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Daily News

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Michael O'Riordan

July 20, 2023

Advertisement

JACC Debuts Data Digest on CV Health in the United States

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

Metformin Before Catheter Ablation for AF Helps Nondiabetic Patients With Overweight

Oral Semaglutide Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients

Weight-Loss Drug MariTide Gains Momentum in Phase II Trial

Eye Condition a ‘Very Rare’ Side Effect of Semaglutide, EMA Says

April 2025 Dispatch for the CV Team

January 2025 Dispatch for the CV Team

Top General Cardiology and Prevention News of 2024

Rural Counties Bore Brunt of Worsening CV Mortality During Pandemic

The Cardiovascular Consequences of War

Can ‘Body Roundness Index’ Replace BMI? That Depends, Say Experts

Medicaid Coverage Improves CV Risk in Some, Post Hoc Analysis Shows

More Data Diminish Support for Cath Lab Fasting Rules: SCOFF

FINEARTS-HF: Benefit of Finerenone Extends to HFmrEF and HFpEF Patients

‘Disproportionate’ Suicide/Self-Harm Signal With Semaglutide: WHO Database

‘Smoldering Epidemic’ of CVD Risk Factors in Middle-Aged Adults

October 2023 News Roundup

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content